(S1 (S (NP (NP (NP (NN Cloning)) (CC and) (NP (NN expression))) (PP (IN of) (NP (DT the) (NN adenosine) (NN kinase) (NN gene))) (PP (IN from) (NP (UCP (NP (NN rat)) (CC and) (ADJP (JJ human))) (NNS tissues))) (. .))))
(S1 (S (S (NP (NN Adenosine) (NN kinase)) (VP (VP (VBZ is) (ADJP (JJ ubiquitous) (PP (IN in) (NP (NNS eukaryotes))))) (CC and) (VP (VBZ is) (NP (DT a) (JJ key) (NN enzyme)) (PP (IN in) (NP (NP (DT the) (NN regulation)) (PP (IN of) (NP (NP (DT the) (JJ intracellular) (NNS levels)) (PP (IN of) (NP (NP (NN adenosine)) (, ,) (NP (NP (DT an) (ADJP (ADJP (JJ important)) (ADJP (JJ physiological))) (NN effector)) (PP (IN of) (NP (NP (JJ many) (NNS cells)) (CC and) (NP (NNS tissues)))))))))))))) (. .)))
(S1 (S (S (PP (IN In) (NP (DT this) (NN paper))) (NP (PRP we)) (VP (VBP report) (NP (NP (DT the) (NN cloning)) (PP (IN of) (NP (NP (NNS cDNAs)) (VP (VBG encoding) (NP (NP (NN adenosine) (NN kinase)) (PP (IN from) (NP (UCP (CC both) (NP (NN rat)) (CC and) (ADJP (JJ human))) (NNS tissues)))))))))) (. .)))
(S1 (S (S (NP (NP (CD Two) (JJ distinct) (NNS forms)) (PP (IN of) (NP (NN adenosine) (NN kinase) (NN mRNA)))) (VP (VBD were) (VP (VBN identified) (PP (IN in) (NP (JJ human) (NNS tissues)))))) (. .)))
(S1 (S (S (NP (NP (NN Sequence) (NN variation)) (PP (IN between) (NP (DT the) (CD two) (NNS forms)))) (VP (VP (VBZ is) (ADJP (JJ restricted) (PP (TO to) (NP (NP (DT the) (JJ extreme) (NN 5'-end)) (PP (IN of) (NP (DT the) (NN adenosine) (NN kinase) (NN mRNA))) (, ,) (PP (VBG including) (NP (NP (DT a) (NN portion)) (PP (IN of) (NP (DT the) (VBG coding) (NN region))))) (, ,))))) (CC and) (VP (VBZ is) (ADJP (JJ consistent) (PP (IN with) (NP (NP (JJ differential) (NN splicing)) (PP (IN of) (NP (DT a) (JJ single) (JJ transcriptional) (NN product))))))))) (. .)))
(S1 (S (S (NP (PRP We)) (VP (VBP have) (S (VP (VP (VBD expressed) (NP (DT both) (NNS forms)) (PP (IN in) (NP (FW E.) (FW coli)))) (CC and) (VP (VBD produced) (NP (NP (JJ soluble) (JJ active) (NN enzyme)) (SBAR (WHNP (WDT which)) (S (VP (VP (VBZ catalyzes) (NP (NP (DT the) (NN phosphorylation)) (PP (IN of) (NP (NN adenosine)))) (PP (IN with) (NP (JJ high) (JJ specific) (NN activity))) (ADVP (FW in) (FW vitro))) (CC and) (VP (VBZ is) (ADJP (JJ susceptible) (PP (TO to) (NP (JJ known) (NN adenosine) (NN kinase) (NNS inhibitors)))))))))))))) (. .)))
